SFRS12IP1 抗体 (N-Term)
Quick Overview for SFRS12IP1 抗体 (N-Term) (ABIN6746414)
抗原
See all SFRS12IP1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- Human SREK1IP1 / SFRS12IP1
-
预测反应
- Percent identity by BLAST analysis:
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide from N-Terminus of human SREK1IP1 (Q8N9Q2, NP_776190). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Marmoset, Mouse, Rat, Elephant, Guinea pig (100%), Galago, Dog, Bovine, Bat, Horse, Opossum, Zebra finch, Chicken, Lizard (92%), Platypus, Zebrafish (85%).
Type of Immunogen: Synthetic peptide
-
-
anti-SFRS12-Interacting Protein 1 (SFRS12IP1) (AA 71-120) antibody
SFRS12IP1 适用: 人, 小鼠, 大鼠, Cow, 犬, 猴, Bat WB 宿主: 兔 Polyclonal unconjugated
anti-SFRS12-Interacting Protein 1 (SFRS12IP1) (Middle Region) antibodySFRS12IP1 适用: 人, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-SFRS12-Interacting Protein 1 (SFRS12IP1) (N-Term) antibodySFRS12IP1 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-SFRS12-Interacting Protein 1 (SFRS12IP1) (N-Term) antibodySFRS12IP1 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 马, Saccharomyces cerevisiae, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
anti-SFRS12-Interacting Protein 1 (SFRS12IP1) (Middle Region) antibodySFRS12IP1 适用: 人, 小鼠, 大鼠, Cow, 犬, Pig WB 宿主: 兔 Polyclonal unconjugated
anti-SFRS12-Interacting Protein 1 (SFRS12IP1) antibodySFRS12IP1 适用: 人, 小鼠, 大鼠 WB, ELISA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
